AUTHOR CORRECTION
Volume 6, no. 1, e00927-20, 2021, https://doi.org/10.1128/mSphere.00927-20. In the author byline, Darin Carroll’s middle initial should be “S.”
. 2021 Feb 17;6(1):e00126-21. doi: 10.1128/mSphere.00126-21
Correction for Hutson et al., “Pharmacokinetics and Efficacy of a Potential Smallpox Therapeutic, Brincidofovir, in a Lethal Monkeypox Virus Animal Model”
Christina L Hutson
a,✉, Ashley V Kondas
a, Mathew R Mauldin
a, Jeffrey B Doty
a, Irma M Grossi
b, Clint N Morgan
a,c, Sharon Dietz Ostergaard
d, Christine M Hughes
a, Yoshinori Nakazawa
a, Chantal Kling
a, Brock E Martin
a, James A Ellison
a, Darin S Carroll
a, Nadia F Gallardo-Romero
a, Victoria A Olson
a
Christina L Hutson
aPoxvirus and Rabies Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
Find articles by Christina L Hutson
Ashley V Kondas
aPoxvirus and Rabies Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
Find articles by Ashley V Kondas
Mathew R Mauldin
aPoxvirus and Rabies Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
Find articles by Mathew R Mauldin
Jeffrey B Doty
aPoxvirus and Rabies Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
Find articles by Jeffrey B Doty
Clint N Morgan
aPoxvirus and Rabies Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
cOak Ridge Institute for Science and Education, CDC Fellowship Program, Oak Ridge, Tennessee, USA
Find articles by Clint N Morgan
Sharon Dietz Ostergaard
dAnimal Resources Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
Find articles by Sharon Dietz Ostergaard
Christine M Hughes
aPoxvirus and Rabies Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
Find articles by Christine M Hughes
Yoshinori Nakazawa
aPoxvirus and Rabies Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
Find articles by Yoshinori Nakazawa
Chantal Kling
aPoxvirus and Rabies Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
Find articles by Chantal Kling
Brock E Martin
aPoxvirus and Rabies Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
Find articles by Brock E Martin
James A Ellison
aPoxvirus and Rabies Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
Find articles by James A Ellison
Darin S Carroll
aPoxvirus and Rabies Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
Find articles by Darin S Carroll
Nadia F Gallardo-Romero
aPoxvirus and Rabies Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
Find articles by Nadia F Gallardo-Romero
Victoria A Olson
aPoxvirus and Rabies Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
Find articles by Victoria A Olson
aPoxvirus and Rabies Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
bChimerix, Durham, North Carolina, USA
cOak Ridge Institute for Science and Education, CDC Fellowship Program, Oak Ridge, Tennessee, USA
dAnimal Resources Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
Citation Hutson CL, Kondas AV, Mauldin MR, Doty JB, Grossi IM, Morgan CN, Ostergaard SD, Hughes CM, Nakazawa Y, Kling C, Martin BE, Ellison JA, Carroll DS, Gallardo-Romero NF, Olson VA. 2021. Correction for Hutson et al., “Pharmacokinetics and efficacy of a potential smallpox therapeutic, brincidofovir, in a lethal monkeypox virus animal model.” mSphere 6:e00126-21. https://doi.org/10.1128/mSphere.00126-21.
✉
Corresponding author.
Collection date 2021 Jan-Feb.
This is a work of the U.S. Government and is not subject to copyright protection in the United States. Foreign copyrights may apply.
PMCID: PMC8544885 PMID: 33597175
This corrects the article "Pharmacokinetics and Efficacy of a Potential Smallpox Therapeutic, Brincidofovir, in a Lethal Monkeypox Virus Animal Model", e00927-20.